Zobrazeno 1 - 10
of 400
pro vyhledávání: '"Jeffrey J Swigris"'
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Dyspnea impairs quality of life (QOL) in patients with fibrotic hypersensitivity pneumonitis (FHP). The Living with Pulmonary Fibrosis questionnaire (L-PF) assesses symptoms, their impacts and PF-related QOL in patients with any f
Externí odkaz:
https://doaj.org/article/5014256a048c4f8f8f5d9fbcfc7124a7
Autor:
Kerri I. Aronson, Mangala Rajan, Janani Varadarajan, Tessy K. Paul, Jeffrey J. Swigris, Jamuna K. Krishnan, Robert J. Kaner, Fernando J. Martinez, Monika M. Safford, Laura C. Pinheiro
Publikováno v:
ERJ Open Research, Vol 10, Iss 4 (2024)
Rationale and objective Disease-specific health-related quality of life (HRQOL) instruments enable us to capture domains that are most relevant to specific patient populations and are useful when a more individualised approach to patient assessment i
Externí odkaz:
https://doaj.org/article/569a28d2189c441da7a1ea7ece7d9b89
Publikováno v:
BMJ Open Respiratory Research, Vol 10, Iss 1 (2023)
Many patients with fibrosing interstitial lung disease (fILD) will need to use supplemental oxygen (O2) to maintain normoxia at some point in their illness. If it is not needed at the time of diagnosis, then if fILD progresses—or if a comorbid cond
Externí odkaz:
https://doaj.org/article/2b002efcf9534738b7a3f46a67514691
Publikováno v:
BMJ Open Respiratory Research, Vol 10, Iss 1 (2023)
Background Interstitial lung disease due to rheumatoid arthritis (RA-ILD) affects a substantial minority of patients with RA, inducing life-altering symptoms, impairing quality of life (QOL) and forcing patients to confront the potential for shortene
Externí odkaz:
https://doaj.org/article/b3cca9f732844bb4b6b5c033330d1e74
Autor:
Timothy M. Wilson, Joshua J. Solomon, Stephen M. Humphries, Jeffrey J. Swigris, Faduma Ahmed, Hong Wang, Erika Darrah, M. Kristen Demoruelle
Publikováno v:
The American Journal of the Medical Sciences. 365:480-487
Autor:
Evans R. Fernández Pérez, James L. Crooks, Jeffrey J. Swigris, Joshua J. Solomon, Michael P. Mohning, Tristan J. Huie, Matthew Koslow, David A. Lynch, Steve D. Groshong, Kaitlin Fier
Publikováno v:
ERJ Open Research, Vol 7, Iss 2 (2021)
Hypersensitivity pneumonitis (HP) is an immunologically mediated form of lung disease resulting from inhalational exposure to any of a large variety of antigens. A subgroup of patients with HP develops pulmonary fibrosis (fibrotic HP; FHP), a signifi
Externí odkaz:
https://doaj.org/article/8b2a2e3a430240638b520ad9129b5e1a
Publikováno v:
International Journal of Nursing Sciences, Vol 6, Iss 1, Pp 38-42 (2019)
Objective: This paper aims to determine the reliability and validity of the Chinese version of a tool that assesses the quality of life in idiopathic pulmonary fibrosis (cATAQ-IPF) in patients with interstitial lung disease (ILD). Methods: We used th
Externí odkaz:
https://doaj.org/article/86324ae1c6834f0cacbd42a8c50b82eb
Autor:
Erica Farrand, Jeffrey J. Swigris
Publikováno v:
Current Opinion in Pulmonary Medicine. 29:322-327
Autor:
Franck Rahaghi, John A Belperio, John Fitzgerald, Mridu Gulati, Robert Hallowell, Kristin B Highland, Tristan J Huie, Hyun J Kim, Martin Kolb, Joseph A Lasky, Brian D Southern, Jeffrey J Swigris, Joao A de Andrade
Publikováno v:
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, Vol 15 (2021)
Purpose: Nintedanib is an approved treatment for idiopathic pulmonary fibrosis (IPF), which slows disease progression. Management of patients with IPF receiving nintedanib can be complicated by tolerability issues, comorbidities, and concomitant medi
Externí odkaz:
https://doaj.org/article/dca028738ba248b488b444b301cd91bc
Autor:
Michael P. Mohning, Isabelle Amigues, M. Kristen Demoruelle, Evans R. Fernández Pérez, Tristan J. Huie, Rebecca K. Keith, Amy L. Olson, Zulma X. Yunt, Jonathan H. Chung, Stephen Hobbs, Jeffrey J. Swigris, Joshua J. Solomon
Publikováno v:
ERJ Open Research, Vol 7, Iss 1 (2021)
Externí odkaz:
https://doaj.org/article/b90214532cd74f2d8888596605f36e96